The human amyloid precursor protein binds copper ions dominated by a picomolar affinity site in the helix-rich E2 domain. by Young,  Tessa R. et al.
Durham Research Online
Deposited in DRO:
08 August 2018
Version of attached ﬁle:
Accepted Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Young, Tessa R. and Pukala, Tara L. and Cappai, Roberto and Wedd, Anthony G. and Xiao, Zhiguang (2018)
'The human amyloid precursor protein binds copper ions dominated by a picomolar aﬃnity site in the
helix-rich E2 domain.', Biochemistry., 57 (28). pp. 4165-4176.
Further information on publisher's website:
https://doi.org/10.1021/acs.biochem.8b00572
Publisher's copyright statement:
This document is the Accepted Manuscript version of a Published Work that appeared in ﬁnal form in Biochemistry,
copyright c© American Chemical Society after peer review and technical editing by the publisher. To access the ﬁnal
edited and published work see https://doi.org/10.1021/acs.biochem.8b00572.
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
  
The Human Amyloid Precursor Protein Binds Copper Ions with  
Dominant Picomolar Affinity via the Helix-Rich E2 Domain 
 
 
 
Tessa R. Young,a Tara L Pukala,b Roberto Cappai,c Anthony G. Wedd a and Zhiguang Xiao*a,d 
 
a School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, 
The University of Melbourne, Parkville, Victoria 3010, Australia 
b Discipline of Chemistry, The University of Adelaide, Adelaide, SA 5005, Australia 
c Department of Pharmacology and Therapeutics, The University of Melbourne, Parkville, Victoria, 
3010, Australia. 
d Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The 
University of Melbourne, Parkville, Victoria, 3052, Australia. 
 
* zhiguang.xiao@florey.edu.au 
 
 
 
Electronic Supplementary Information   
  S       2 
EXPERIMENTAL PROCEDURES 
1.  Materials and general methods 
Reagents including buffers (Mops, Mes, Ches), ligands (Fs, Fz, Bca, Bcs), metal salts 
(CuSO4•5(H2O), Cu(OAc)2•(H2O), reductants (NH2OH, Asc) and heparin (H3393, from porcine 
intestinal mucosa) were purchased from Sigma-Aldrich and were used as received. Heparin 
concentrations were estimated by mass, assuming an average molar mass of 19 kDa for the H3393 
mixture.1 Cu(II) standards were prepared by dissolving cupric salts in Milli-Q water. Their 
concentrations were calibrated via reaction with excess ligand Bcs in MOPS buffer containing 
reductant NH2OH. Under such conditions, copper ions are converted quantitatively to the 
chromophore [CuI(Bcs)2]3- (lmax, 483 nm; e = 13,000 M-1 cm-1).2 Peptide probes (DP1-3) were 
custom synthesised by GL Biochem (Shanghai), using Fmoc-L-Lys(dansyl)-OH to supply the dansyl 
moiety at the ε-amino group of the sole lysine residue in each peptide sequence. The identity and 
purity (> 98%) of each peptide was confirmed by electrospray ionisation mass spectrometry (ESI-
MS) and HPLC, and concentrations determined spectroscopically (λmax ~	 326 nm; 
e = 4500 M-1 cm-1). Human serum albumin (HSA) was purchased from Sigma Aldrich as a 
lyophilised powder. Its purity was confirmed by SDS-PAGE and spectroscopy (λmax ~	280 nm; e = 
34,445 M-1 cm-1).  
The protein domains and their Cu(II)-complexes tended to precipitate in neutral buffer solutions 
but increased ionic strength via NaCl, enhanced solubility. In competition experiments, a standard 
NaCl concentration (100 mM) was used. In cases where high concentrations of protein were required, 
the concentration of NaCl was adjusted accordingly, as indicated in the text.   
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2.  Expression and purification of APP E2 domain from Escherichia coli 
Protein domains APP E2 (residues 295-498 of APP695) and E2-qm (a quadruple mutant with the four 
His residues of the M1 site converted to Ala: H313,382,432,436A) were expressed in Escherichia 
coli BL21(DE3) cells and purified as reported.3 These were generated in their N-terminal acetylated 
forms by co-expression of a NatB acetylation complex, as previously described.3,4 
 
3.  Expression of APP domains D1, D2, E1 and sAPPα from Pichia pastoris 
The complete extracellular domain sAPPα (residues 18-611) of APP and the separate subdomains D1 
(28-123), D2 (133-189) and E1 (28-189) were expressed and purified from Pichia pastoris cells 
according to published procedures.5-8 The Pichia pastoris cells transformed with the respective 
expression plasmids were grown for ~ 48 hrs in YPD media in shaking flasks (30 °C, 150 rpm). Cells 
were then pelleted and protein expression induced by resuspending the harvested cells in induction 
(YPM) media and incubating cultures (30 °C, 150 rpm) for 48 – 72 hrs. Cultures were then centrifuged 
(3000 g, 30 mins, 4 °C) and the supernatant, containing the secreted recombinant protein target, was 
collected and filtered through a 0.2 µm membrane. Protein purification was conducted using a 
variation on previously described methods,5,9 as outlined below.  
 
4.  Purification of APP domains D1, D2, E1 
Culture supernatant in buffer solution (20 mM sodium phosphate, pH 7.4, 500 mM NaCl, 10 mg/L 
PMSF) was loaded onto a Cu(II)-NTA resin, washed with 10 CVs high-salt buffer (20 mM sodium 
phosphate, pH 7.4, 500 mM NaCl) and eluted with imidazole solution (20 mM sodium phosphate, 
pH 7.4, 500 mM NaCl, 250 mM imidazole). Elution fractions were purified by size-exclusion 
chromatography using a Superdex 75 HiLoad 16/60 column (GE Healthcare) in Mops buffer (20 mM, 
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pH 7.4, 100 mM NaCl). For domains D1 and D2 only, an additional hydrophobic interaction 
chromatography (HIC) step was required. Protein fractions were diluted with an equal volume of 
binding buffer (50 mM sodium phosphate, pH 7.0, 2.0 M (NH4)2SO4) and loaded to a HiLoad 16/10 
phenyl sepharose column (GE Healthcare). The column was washed with buffer (50 mM sodium 
phosphate, pH 7.0, 1.0 M (NH4)2SO4) and eluted with a linear (NH4)2SO4 gradient (1.0 – 0 M). 
Collected fractions were concentrated and buffer exchanged (20 mM Mops, pH 7.4, 100 mM NaCl) 
using centrifugal filters and stored at –80 °C. 
 
5.  Purification of full length sAPPα 
Culture supernatant in buffer solution (20 mM L-histidine, pH 5.7, 50 mM EDTA, 10 mg/L PMSF) 
was loaded onto a DE-52 anion exchange resin (Whatman), washed with 10 CVs wash buffer (20 
mM L-His, 5 mM EDTA, 150 mM NaCl, 10 mg/L PMSF) and eluted with a linear (150 – 800 mM) 
NaCl gradient. Protein-containing elution fractions were diluted with an equal volume of binding 
buffer (50 mM sodium phosphate, pH 7.0, 2.0 M (NH4)2SO4) and loaded onto a HiLoad 16/10 phenyl 
sepharose column (GE Healthcare). The column was washed with buffer (50 mM sodium phosphate, 
pH 7.0, 1.0 M (NH4)2SO4) and eluted with a linear (NH4)2SO4 gradient (1.0 – 0 M). Elution fractions 
separated into sAPPα and a truncated fragment (sAPPα-tr), which were each separately purified by 
size-exclusion chromatography on a Superdex 200 10/300 GL column (GE Heathcare) in Mops buffer 
(20 mM, pH 7.4, 100 mM NaCl). Collected fractions were concentrated using centrifugal filters and 
stored at –80 °C. Protein purity was confirmed by SDS-PAGE and UV-visible spectroscopy. The 
latter was used to confirm the removal of highly-absorbing media contaminants from Pichia 
supernatants. The spectra of purified samples showed a single peak centred at 280 nm, and an 
absorbance ratio of A260 : A280 ~ 0.6 characteristic of the purified protein (see Figures S1b, S2). 
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6.  Protein identification and quantification 
The identity of each purified APP protein domain was confirmed by ESI-MS analysis (Table 1). The 
single exception is sAPPα whose identity was confirmed by in-gel trypsin digestion (with in-gel 
reduction-alkylation steps) and LC-MS peptide mapping (Figures S3, S4), following reported 
protocols.10  The details are given in section 7 below. 
Protein concentrations were estimated based on solution absorbance at 280 nm using molar 
extinction coefficients calculated from their respective amino acid compositions assuming all 
cysteines form disulfide bonds: ε = 15,930 cm-1 M-1 for E2 proteins; 15,845 cm-1 M-1 for D1; 
7,365 cm-1 M-1 for D2; 23,210 cm-1 M-1 for E1; and 60,110 cm-1 M-1 for sAPPα.  
 
7.  Identification and characterisation of sAPPα 
sAPPα was expressed in the methylotrophic yeast Pichia pastoris and isolated as two major protein 
species: (i) the full-length sAPPα ectodomain and (ii) a smaller truncated species (sAPPα-tr), 
presumably derived from partial degradation of the full length protein during isolation (Figure S1a), 
as reported previously5. The two species were isolated and characterised separately. Spectroscopic 
data (Figure S1b) indicated a high purity of both samples.  
 A high degree of heterogeneity from PTMs prevented sequence identification from high-
resolution ESI-MS. Instead, samples of both the sAPPα and sAPPα-tr were excised from SDS-PAGE 
gels and subject to an in-gel trypsin digestion, to identify the peptide fragments present in the 
respective protein species. Fragments detected in the full-length and truncated protein samples are 
indicated in red on the sequences in Figure S3. In both samples, the N-terminal fragment 
‘RGFPGMLEVPTDGNAGLLAEPQIAMFCGR’ was detected (with a single missed trypsin 
cleavage after the first arginine), indicating that both the full-length and truncated proteins retain their 
complete N-terminal sequence. In sAPPα protein samples, the C-terminal fragment 
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‘HDSGYEVHHQ’ was detected suggesting that the entire amino acid sequence is intact in this 
species (Figure S3a). However, the fragment closest to the C-terminus that was detected in sAPPα-tr 
samples was ‘EQNYSDDVLANMISEPR’ (Figure S3b), suggesting that this species is truncated 
from the C-terminal end by approximately 100 residues. This ~11 kDa section of the protein 
sequence corresponds to the unstructured juxtamembrane region (JMR) connecting E2 to the 
transmembrane domain (Figure 1) and is therefore likely susceptible to protein degradation during 
the expression/isolation procedure.  
For additional characterisation, both samples were chemically deglycosylated by treatment with 
trifluoromethanesulfonic acid (TFMS) which cleaves all N- and O-linked glycosylations except the 
innermost N-linked GlcNAc or the innermost O-linked GalNAc, while leaving the peptide backbone 
intact.11 Deglycosylation was carried out with a Glycoprofile IV Chemical Deglycosylation kit 
(Sigma Aldrich). Anhydrous TFMS (150 µL) with 10% anisole was added to lyophilised protein 
samples (~1.0 mg) and incubated for 2 hours on ice to initiate deglycosylation. Reactions were then 
quenched with 20 µL additions of pyridine (cooled on dry-ice) in the presence of bromophenol blue 
(0.2 %) until excess acid had been neutralised (as indicated by colour change). Samples were dialysed 
against 3×500 mL buffer (10 mM Tris, pH 8) to remove excess pyridine prior to SDS-PAGE and MS 
analysis (Figure S4).   
After subjecting sAPPα-tr to chemical deglycosylation, SDS-PAGE reveals a small decrease in 
molecular weight, indicative of the removal of glycans from the protein backbone (Figure S4b).  
There was a significant improvement in resolution of the resulting mass spectrum (Figure S4c versus 
Figure S4a) which was deconvoluted to reveal a major species of approximately 57 kDa (Figure S4d), 
a mass ~11 kDa less than the expected MW (68.3 kDa) for the full-length protein backbone. The data 
supports the identification of this protein as a truncated form of the APP ectodomain including the 
intact N-terminus, E1, acidic and E2 domains but lacking the C-terminal JMR. Despite several 
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attempts to chemically deglycosylate the full-length sAPPα, a sufficiently resolved mass spectrum 
appropriate for mass deconvolution could not be obtained. Notably, the majority of reported 
glycosylation sites are located at the C-terminus of sAPPα in the JMR (Figure 1) a likely rationale 
for less efficient deglycosylation in sAPPα samples.  
 All ectodomain copper-binding studies reported in this work were performed with the full-
length sAPPα. 
 
8.  Ternary Complex Isolation 
Samples of reaction mixtures (~1.0 mL) containing copper (30 µM, added as CuSO4), Bca (80 µM), 
reductant NH2OH (1.0 mM) and selected APP proteins (30 µM each) were applied to a desalting gel 
filtration column (Econo-Pac 10DG packed with P6-DG gel, Bio-Rad) equilibrated in Mops buffer 
(50 mM, pH 7.4, 100 mM NaCl). Continued addition of buffer induced gravity flow through the resin. 
Elution fractions (1.0 mL) were collected and the UV-visible absorbance spectrum of each fraction 
was recorded. Protein fractions eluted at ~4.0 mL while small molecules (ie Bca) eluted at ~10.0 mL. 
The spectra of protein fractions are shown in Figure S6. Detected absorbance at 335 nm 
(corresponding to ligand Bca) in protein fractions indicates ternary complex formation. See ref 3 for 
further details. 
 
9.  Spectroscopic methods 
UV-visible spectra were recorded on a Varian Cary 300 spectrophotometer in dual beam mode with 
quartz cuvettes of 1.0 cm path length. All titrations with metal ions were performed in appropriate 
buffers and corrected for baseline. Fluorescence emission spectra were recorded on a Varian Cary 
Eclipse spectrophotometer with a band pass of 20 nm for both excitation and emission. The excitation 
wavelength for the dansyl probes was λ = 330 nm and the emission spectra were recorded between λ 
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= 450-750 nm at a scale rate of λ = 600 nm min-1. Circular dichroism spectra were recorded on a 
Chirascan-plus spectrometer (Applied Photophysics) using a 0.1 cm quartz cell. Spectra were 
averaged from three scans and a baseline was subtracted from each recorded spectrum. 
Electron paramagnetic resonance (EPR) spectra were recorded on Bruker Elexsys E 500 EPR 
spectrometer. Samples of CuII-E2 and CuII-HSA were prepared by adding 0.9 equivalents Cu(II) into 
apo-proteins (each 225 µM) in an appropriate buffer (50 mM) containing 500 mM NaCl and ~10% 
glycerol. Samples containing both E2 and HSA were prepared by adding limiting concentrations of 
Cu(II) (120 µM) into a mixture of the two apo-proteins (150 µM each) in buffer of appropriate pH. 
Samples were snap-frozen in liquid nitrogen and the spectra recorded at 77 K in a liquid-nitrogen 
finger Dewar. EPR recording conditions: microwave frequency was in the range ν = 9.446 – 9.495 
GHz for all samples, but converted to a single frequency of 9.475 GHz for reporting via relationship 
g = 714.48 ν/F, where F is the magnetic field in Gauss units, and g is the proportionality constant; 
microwave power 0.633 mW, modulation amplitude 4 G, sweep time 40 s, time constant 20 ms, 
average number of scans 30.   
 
10.  Quantification of Cu(I) binding 
Cu(I) binding affinities of APP domains were quantified using the probe ligands Fs, Fz and Bca, 
following reported protocols.12 Each ligand forms a chromophoric Cu(I) complex ([CuIL2]3-) with 
defined spectroscopic properties listed in Table S2. Quantification was based on the following 
relationships: 
  Cu%L' 	+ 	T			 ⇌ 			Cu%T	 + 	2L  (S1) 
    𝐾-. = 	 012345[7]9[12379][4] = 	 :;<=9 (S2) 
 [4]>?>[123]>?> 	= 	1 −	 [12379][123]>?> 	+	𝐾B	𝛽' D [7]>?>[12379] 	– 	2F' [Cu%L'] D1 −	 [12379][123]>?>F	     (S3) 
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where KD is the conditional dissociation constant of target protein T, and β2 is the known stepwise 
formation constant of the [CuIL2]3- probe complex (Table S2). Cu(I) speciation was defined using 
absorbance data to determine equilibrium concentrations of [CuIL2]3-. Eqn S3 is derived from eqn S2 
incorporating mass balance relationships for an effective competition described by eqn S1. Eqn S3 
was used for curve-fitting of the experimental data to derive conditional dissociation constants (𝐾BG ) 
for target proteins. 
 
11.  Quantification of Cu(II) binding  
Cu(II) binding of APP domains and HSA were quantified using a series of fluorescent DP probes, 
following reported protocols.13 These probes feature a dansyl group and emit intense fluorescence at 
lmax ~550 nm upon excitation at ~330 nm. Each probe binds one equiv of Cu(II) with varying 
affinities. Cu(II) binding to probes was sensitively detected by proportional fluorescence quenching 
and quantified based on the following relationships: 
 Cu%%DP	 + 		T		 ⇌ 		 Cu%%T	 + 	DP       (S4) 
 𝐾-J = 	 [12334][BK][1233BK][4] 		= 		 ;<L1233BKM;<(12334)        (S5) 
           [4]>?>[BK]>?> = 	 [12]>?>	–	[1233BK][BK]>?> 	+ 		 ;<L12334M;<(1233BK) 	D [12]>?>[1233BK] − 1F D1 −	 [1233BK][BK]>?> F  (S6) 
           [1233BK][BK]>?> 	= 	 PQRP	PQRPS 	= 	 TP	TPS       (S7) 
where KD(CuIIT) and KD(CuIIDP) are the conditional dissociation constants for target and probe 
ligands, respectively. Eqn S6 is derived from eqn S5 incorporating the mass balance relationships for 
an effective competition described by eqn S4 and is a convenient format for curve-fitting of the 
experimental data to derive KD(CuIIT) with known KD(CuIIDP) (Table S2). The fluorescence intensity 
at 550 nm was monitored at each titration point to define Cu(II) speciation via eqn S7 where Fo, F 
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and F1 are the fluorescence intensities of the DP probe upon binding 0, < 1.0 and 1.0 equiv of Cu(II), 
respectively. Best fits of the experimental data to eqn S6 were used to extract target dissociation 
constants. Reaction kinetics were fast for competition experiments between APP domains and probes 
DP1-3, and continuous titrations were employed in these experiments. Similar competitions between 
protein HSA and probes DP3 were slow to reach equilibrium, and a series of solutions were prepared 
and equilibrated 1-2 hours before fluorescence measurements. 
Target KD values were determined at a range of pH values in appropriate buffers (50 mM: Mes 
pH 5.6 – 6.7, Mops pH 6.8 – 8.1, Ches pH 8.7 – 9.2; 100 mM NaCl). The pH-dependent aﬃnities of 
the Cu(II) probes DP2–4 are available (pH 6.2 – 9.2);13 affinity characterisation of probe DP3 was 
extended to cover a broader pH range (5.6 – 9.2) in this work (Figure S14). The relationship between 
conditional affinity (KD) and pH can be modelled using eqn S8, under conditions that (i) the Cu(II) 
binding site remains unchanged over the modelled pH range; and (ii) ligand compositions are known: 
𝐾V = 𝐾BWXY(1 + ∑ 10(∑ \;]^R_\`)a^bSc_d: )     (S8) 
The conditional affinity data for APP-E2, collected from pH 5.6 – 7.4, was fitted by eqn S8, assuming 
n = 4 coordinating ligands with equivalent pKa, to derive a best-fit absolute affinity (KDabs) and 
pKa(His).   
 
12.  Ion mobility-mass spectrometry 
Protein samples were exchanged into ammonium acetate buffer (10 mM; pH 7.4) using centrifugal 
filters. Cu(II) ions were added from a copper(II) acetate standard. IM-MS spectra were acquired on a 
Synapt HDMS system (Waters, Manchester, U.K.), using nano-ESI in the positive ion mode. 
Platinum-coated borosilicate capillary needles (prepared in-house) were used for sample introduction. 
To optimise resolution of solution relevant structures, instrument settings were modified slightly from 
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typical values: capillary voltage, 1.7 kV; cone voltage, 40 V; trap collision energy, 20 V; source 
temperature, 50 °C; backing pressure, 4 mbar; IMS cell pressure (N2), 0.4 mbar; traveling wave 
velocity, 300 ms−1; traveling wave height, 6 V. The native MS data and drift time measurements were 
analysed using combined MassLynx and Driftscope software packages (Waters, Manchester, U.K., 
version 4.1). Extracted drift times corresponding to specific charge state ions were selected and 
converted to collision cross sections (CCSs) following reported protocols.14,15 Briefly: IM-MS spectra 
for calibration samples (ubiquitin, myoglobin and cytochrome c; denatured conditions) were acquired 
and drift times of calibrant ions extracted. A nonlinear function was optimised to fit the calibration 
data as described in ref 14, using reference CCS values from the literature.15 The same function was 
applied to samples of interest (acquired under identical machine settings to calibrant ions) to calculate 
CCSs for these unknowns. An estimate of the error in CCS measurement is 8−10%.14 CCSs of model 
protein structures were calculated using the IMPACT projection approximation algorithm.16 
Structural coordinates used as input were obtained from the Protein Data Bank (PDB) with accession 
numbers indicated in the text. 
 
13.  Formal reduction potential 
Formal reduction potentials were estimated from the Nernst relationship of eqn S9: 
𝐸	(mV) = 𝐸h + 59	log D;<(1233);<(123) F     (S9) 
using the relative affinities of the E2 site for Cu(I) and Cu(II) ions at pH 7.4. E0 = 153 mV (vs SHE) 
is the standard reduction potential of Cu2+/Cu+.17  
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14.  Catalytic aerobic oxidation of ascorbate 
Reaction solutions were prepared in Mops buffer (50 mM, pH 7.4, 100 mM NaCl). Asc was added 
as the final component of solutions to initiate the reaction, and the change in absorbance spectrum 
(265 nm) was recorded for 15 mins following addition of reductant. Control solutions, prepared 
without Asc, were used for baseline correction. Rates were extracted from linear regions of the 
reaction, before Asc concentrations had become limiting.  
 
15.  Protein oxidation analysis 
Samples were prepared as described in Table 4 and incubated for 1 hour before quenching reactions 
with excess EDTA (100 µM). Samples were then stored at 4°C prior to ESI-MS analysis, performed 
under denaturing conditions, as reported previously.3  
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Table S1. Properties of chromophoric Cu(I) complexes used in this work a 
Ligand λmax of [CuIL2]3- (nm) Ɛ λmax (cm-1 M-1) log β2 
Fs 484 6,700 13.7 
Fz 470 4,320 15.1 
Bca 562 7,900 17.2 
 358 42,900 b  
a Data from refs 12. b With reference to equivalent copper-free Bca ligand solution (see ref 18).  
 
 
 
Table S2. Properties of fluorescent Cu(II) probes used in this work a 
Probe F1/F0 (550 nm) log KD 
DP1 0.15 –8.1 
DP2 0.17 –10.1 
DP3 0.13 –12.3 
a At pH 7.4; F0 and F1 refer to F550 for apo-DP and CuII-DP under identical 
conditions; for characterisation of probe properties at varying pH see 
Table 3 and Figure S14 of this work, and refs 13,19.  
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Table S3. Cu(II) affinities of APP domains at various pH 
Protein  log KD at given pH a  
 5.6 6.7 7.4 
E1b > –6 >8.4 > –9.4 
E2 –7.9 –10.7 –11.4 
sAPPα –7.8 –10.6 –11.4 
a  Dissociation constants were determined using competition experiments with probe DP3.  b Under 
identical conditions used for all experiments, E1 sites are too weak to compete effectively with 
probe DP3 for Cu(II) binding, and only upper affinity limit is given. 
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Figure S1. Purification of sAPPα from Pichia pastoris: (a) SDS-PAGE analysis of protein fractions 
during purification. Lanes: 1 supernatant, 2 elution from anion-exchange resin DE52, 3 isolated full 
length sAPPα, 4 protein marker, 5 isolated sAPP-tr (truncated protein) (b) UV-Visible absorbance 
spectra for isolated proteins (indistinguishable between sAPPα and sAPP-tr). 
 
 
 
 
Figure S2. Representative analysis of Pichia-derived protein (APP-D1) at various stages of 
purification. UV-visible absorbance of APP-D1 elution fractions from (i) Cu-IMAC; (ii) size 
exclusion chromatography (SEC); (iii) hydrophobic interaction chromatography (HIC).  
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Figure S3. Peptide fragments identified from in-gel trypsin digestion of sAPPα (a) and sAPP-tr (b) 
protein samples. Peptide fragments identified from tryptic digest are highlighted in red, and 
undetected peptides are coloured black.   
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Figure S4. Analysis of truncated APP ectodomain (sAPP-tr) before and after chemical 
deglycosylation by treatment with trifluoromethanesulfonic acid (TFMS). (a) ESI-MS spectrum of 
protein before (a) and after (c) TFMS treatment. (b) SDS-PAGE shows small decrease in protein MW 
after TFMS treatment. (d) Deconvolution of mass spectra from (c). 
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Figure S5. Quantification of Cu(I) binding affinities. Changes in solution spectra of Cu(I) 
chromophoric probes [CuIL2]3- (L = Fs, Fz or Bca) upon titration of: (a, b) APP D1 (or D2 or E1) into 
a Mops solution (pH 7.4, 1.0 mM NH2OH, 0.5 mM Asc) containing [Cu(I)]tot = 30.3 µM and [Fs]tot 
= 70 µM (a) or [Cu(I)]tot = 55 µM and [Fz]tot = 140 µM (b); (c) APP E2 into a Mops solution (pH 7.4, 
1.0 mM NH2OH) containing [Cu(I)]tot = 7.2 µM and [Bca]tot = 16.6 µM in the presence of one equiv 
of heparin H3393 (relative to protein). Shown in inset of (a) are two curve-fittings of the experimental 
[CuI(Fs)2]3- concentrations versus the ratio of [D1]tot/[Cu]tot (i) and [D2]tot/[Cu]tot (ii), respectively, 
allowing derivation of log KD values for APP D1 and D2 as listed in Table 2. Shown in inset of (b) is 
a curve-fitting of the experimental [CuI(Fz)2]3- concentrations versus the ratio of [E1]tot/[Cu]tot in 
solutions assuming two identical binding sites in E1, allowing derivation of an average log KD = -
10.3 for the two sites. Equivalent curve-fittings for other experiments are shown in main Figure 3. 
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Figure S6. Solution spectra of protein fraction separated by a desalting gel-filtration column from a 
mixture in Mops buffer (20 mM, pH 7.4, 100 mM NaCl) containing copper (30 µM, added as CuSO4), 
Bca (80 µM), reductant NH2OH (1.0 mM) and selected APP protein domains (30 µM each): (i) E1, 
E2-qm (lacking the tetra-His M1), sAPPα plus heparin (1 eq), or pure protein; (ii) E2; and (iii) sAPPα.  
 
 
 
Figure S7. Quantification of Cu(II) affinities for APP domains: (a) D1 and D2 by titration of the 
respective protein into solution of Cu(II)-DP1 ([CuII]tot = 1.5 µM, [DP1]tot = 2.0 µM); and (b) E1 by 
titration of the protein into a solution of Cu(II)-DP1 ([CuII]tot = 3.8 µM, [DP1]tot = 5.0 µM). Solid 
traces are fitting of experimental data to eqn S6, assuming one or two Cu(II) sites per protein for (a) 
and (b), respectively. The derived log KD values are listed in Table 2. 
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Figure S8. Frozen solution EPR spectra recorded at 77 K for Cu(II)-E2 (compositions: [Cu(II)] = 
150 µM, [E2] = 200 µM in 50 mM buffer, 0.5 M NaCl) at pH 7.4 (Mops), pH 8.7 and 9.2 (Ches). 
 
 
 
Figure S9. Frozen solution EPR spectra recorded at 77 K for the Cu(II) complexes of HSA and APP 
E2 (200 µM each) show consistent signals from pH 6.2 (red traces) to pH 7.4 (blue traces). Insets 
show enlargements of the spectra scaled up by a factor of 4. All solutions were prepared in 50 mM 
buffer (Mes pH 6.2; Mops pH 7.4) with 500 mM NaCl and 10 % glycerol. 
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Figure S10. Kinetics of Cu(II) transfer from a solution of CuII-DP3 ([Cu]tot = 1.6 µM, [DP3]tot = 
2.0 µM) to (i) APP E2 or (ii) HSA (each 2.0 µM) at pH 7.4, followed by change in fluorescence 
intensity at 550 nm (inversely proportional to Cu-DP3 concentration). 
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Figure S11. Arrival time distributions (ATDs) for mass-selected (a) apo-E2 ions; (b) CuII-bound E2 
ions. Charge states are indicated: (i) 9+; (ii) 10+; (iii) 11+; (iv) 12+. All spectra were acquired under 
identical ion-mobility conditions. Corresponding calculated collision cross-sections (CCS) are listed 
in Table 3. 
 
Note:  
(1) The ATD profiles for different apo-E2 ions (9+ to 12+) were all slightly broader than their CuII-
E2 counterparts (Figure S11), suggesting a higher structural flexibility of the apo-form. In 
particular, the ATD for the +12 charge apo-E2 ions was bimodal (Figure S11a(iv)), indicating 
that about half the +12 charge ions were unfolded to a certain extent. In other words, Cu(II) 
binding stabilizes the E2 tertiary structure. 
(2) The derived CCSs for the low charge ions (9+ and 10+) were comparable to the theoretical values 
calculated from the known protein structures for apo- and Cu(II)-bound E2 (Table 3), confirming 
that these low charge ions are dominated by the folded protein forms. 
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Figure S12. Circular dischroism spectra for apo-E2 (black trace) and CuII-E2 (red trace). Protein 
solutions (7.0 µM) were prepared in sodium phosphate buffer (20 mM, pH 7.4, 20 mM NaCl). 
 
 
Figure S13. Size-exclusion chromotographic analysis of the isolated sAPPa in the absence (blue 
trace) and presence (red trace) of heparin, demonstrating that the heparin induced sAPPa 
dimerisation. 
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Figure S14. Extended characterisation of pH-dependent affinities of probe DP3; modelled by eqn S8 
assuming a [-NH2, 3 NIm (His)] Cu(II) site. Solid black trace shows model from ref 13 covering pH 
6.2-9.2; dotted red trace shows new model covering pH 5.6-9.2, deriving log KDabs = -13.7 and pKa = 
9.0 for N-ter -NH2 and an average pKa = 6.3 for 3 His ligands. 
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